Emtricitabine/Tenofovir (PrEP) 30 Tablets

£ 54.99

This product is currently out of stock.

We also sell this product in the following strengths and total quantities. Select the price to take you to the product.

	200mg
30 tablets	£54.99
90 tablets	£149.99
180 tablets	£279.99

Important note: you will need to provide proof of a negative Hepatitis B, C and HIV test before ordering
The HIV test MUST be within the LAST 3 MONTHS.
You should also have had a renal (kidney function test) in the last 12 months too
If you need a test we can supply them - click here for the tests
Generic Truvada (PrEP) tablet to help reduce the risk of HIV transmission
Up to 99% effective when taken daily
Suitable for those who have a current HIV negative status
Discreet, secure online consultation
Not to be used for as a treatment for HIV
Each film-coated tablet contains Emtricitabine 200mg and Tenofovir 245mg

Further information on our service, what is PrEP as well as who it may be suitable for is available below. If you still have questions, our customer care team can assist you here

You will need to read and agree to our Consent form to be able to access this service - copy here to read

What is PrEP?

Emtricitabine/Tenofovir, commonly referred to as PrEP is the generic version of the brand . It is a treatment used to prevent the transmission of HIV and when taken daily is up to 99% effective.

If you are looking to , the generic version includes the same active ingredient at a lower price. There is no difference in the way the medicine works or its effectiveness.

What tests do I need to get PrEP from Oxford Online Pharmacy

So we can prescribe safely you will need proof of the following - you can upload it during the consultation questionnaire or email it to info@oxfordonlinepharmacy.co.uk

Negative test results in the last 3 months for HIV, Hepatitis B and Hepatitis C - tests here
Kidney function test result in the last 12 months - sometimes called Renal function or GFR - click here to obtain our simple blood test

Who should take PrEP?

PrEP tablets may be a good treatment option for you if you are at higher risk of getting HIV and are HIV negative.

You may have a higher risk of getting HIV if you regularly have sex with someone who’s HIV status is unknown to you without a condom and you are:

A man having sex with a man
A woman who has sex with bisexual people
A transgender person who has sex with men
Having sex with someone from a country with a high rate of HIV

Provided you are over 18 years old, have test HIV negative and meet the above criteria Oxford Online Pharmacy can prescribe PrEP to men, women, transgender and non-binary people.

How Do I Buy PrEP (UK)?

Buying PrEP online from Oxford Online Pharmacy is simple, select one of the three sizes that we offer and complete your online consultation. Our doctor will then review your answers to ensure it is the most appropriate option for you.

To place your , we request that you provide the following for your own safety:

Confirmation of a negative result from a recent HIV test
Completion of our health questionnaire

Our highly trained team may contact you for further information to ensure that PrEP is the most appropriate option for you. Please know that this is for your own safety and the information is only used to ensure we are prescribing safely and in line with guidance.

Registered online pharmacies are governed by the same regulations as physical ones. You can check whether a pharmacy is registered in the UK at any time, our registration can be verified here

How Effective is PrEP?

PrEP medication is highly effective according to trials and can reduce your risk of contracting HIV by over 90%.

While you are testing is advised every three months to ensure it is still the most appropriate option for you.

Quick and easy at home HIV testing is available via our website here

Does PrEP Cure HIV?

PrEP is not a HIV cure and should only be taken by those who are HIV negative. It can reduce your risk of contracting HIV by over 90% if taken according to your doctors’ advice.

There is currently no cure for HIV however it can be managed with antiviral drugs. Please contact your doctor or sexual health clinic if you believe you are HIV positive.

Please read the patient information leaflet carefully before taking this medicine. Take this medicine exactly as described by your doctor.

The recommended dosage of Emtricitabine/Tenofovir (PrEP) for most people is one tablet, once daily. Ideally you should take the tablet as the same time each day with food.

You may hear of alternative regimes for taking PrEP however the above offers the lowest risk of contracting HIV and so we will only prescribe based on taking one tablet daily.

The active ingredients of each are Emtricitabine and Tenofovir. Each film-coated tablet contains 200 mg of emtricitabine and 245 mg of tenofovir disoproxil (equivalent to 291.5 mg of tenofovir disoproxil phosphate or 136 mg of tenofovir).

Mylan brand also contains lactose monohydrate. See the Patient Information from the makers of our PreP tablets Mylan Pharmaceuticals here.

All medicines have the possibility to cause side effects, but these can vary from person to person. If you experience any serious ill effects from taking PrEP or any other medication, get medical help immediately.

Possible serious side effects:

Lactic acidosis (excess lactic acid in the blood)

This is a rare but potentially life-threatening side effect. Lactic acidosis occurs more often in women, particularly when overweight, and in people with liver disease. Lactic acidosis may present with the following symptoms:

deep rapid breathing,
drowsiness,
feeling sick (nausea), being sick (vomiting),
stomach pain.

Get medical assistance immediately if you think you may have lactic acidosis.

Possible side effects:

Very common side effects (may affect more than 1 in 10 people):

diarrhoea, being sick (vomiting), feeling sick (nausea),
dizziness, headache,
rash,
feeling weak.

Tests may also show:

decreases in phosphate in the blood,
increased creatine kinase.

Common side effects (may affect up to 1 in 10 people):

pain, stomach pain,
difficulty sleeping, abnormal dreams,
problems with digestion resulting in discomfort after meals, feeling bloated, flatulence,
rashes (including red spots or blotches sometimes with blistering and swelling of the skin), which may be allergic reactions, itching, changes in skin colour including darkening of the skin in patches,
other allergic reactions, such as wheezing, swelling or feeling light-headed.

Tests may also show:

low white blood cell count (a reduced white blood cell count can make you more prone to infection),
increased triglycerides (fatty acids), bile or sugar in the blood,
liver and pancreas problems.

Uncommon side effects (may affect up to 1 in 100 people):

pain in the abdomen (tummy) caused by inflammation of the pancreas,
swelling of the face, lips, tongue or throat,
anaemia (low red blood cell count),
breakdown of muscle, muscle pain or weakness which may occur due to damage to the kidney tubule cells.

Tests may also show:

decreases in potassium in the blood,
increased creatinine in your blood,
changes to your urine.

Rare side effects (may affect up to 1 in 1,000 people):

Lactic acidosis (see Possible serious side effects)
fatty liver,
yellow skin or eyes, itching, or pain in the abdomen (tummy) caused by inflammation of the liver,
inflammation of the kidney, passing a lot of urine and feeling thirsty, kidney failure, damage to kidney tubule cells,
softening of the bones (with bone pain and sometimes resulting in fractures),
back pain caused by kidney problems.

Damage to kidney tubule cells may be associated with breakdown of muscle, softening of the bones (with bone pain and sometimes resulting in fractures), muscle pain, muscle weakness and decreases in potassium or phosphate in the blood.

If you notice any of the side effects listed above or they become serious, seek medical advice from your doctor or pharmacist.

The frequency of the below side effects is unknown:

Bone problems. Some patients taking combination antiretroviral medicines such as Emtricitabine/Tenofovir disoproxil Zentiva may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone). Taking this type of medicine for an extended period, taking corticosteroids, drinking alcohol, having a very weak immune system, and being overweight, may be some of the many risk factors for developing this disease. Signs of osteonecrosis are:
- joint stiffness
- joint aches and pains (especially of the hip, knee and shoulder)
- difficulty with movement

If you notice any of these symptoms tell your doctor.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

Authored by Robert Bradshaw on 12 January 2021. Reviewed by Roisin McHugh on 12 January 2021.